HOME >> BIOLOGY >> NEWS
The contraceptive plague

AFTER more than a decade of trying, Australian researchers have created a highly infectious virus that could wipe out the country's rabbit pests by making them sterile.

The team, at the Pest Animal Control Cooperative Research Centre (PAC CRC) in Canberra, has already applied for permission to carry out field trials with a similar virus that makes European mice infertile. Advocates of this form of biological control say it is more humane than existing strategies such as poisoning, shooting or spreading lethal diseases.

From cats to camels, feral mammals cost Australia hundreds of millions of dollars each year in lost agricultural production and environmental damage, and have driven some native mammals and birds to extinction.

"Australia has lost more mammal species than the rest of the world combined in the past 400 years," says project director Tony Peacock. But the prospect of genetically engineered viruses being released into the wild is still likely to spark a fierce debate.

The viruses make females infertile because they have an added gene for a protein from the zona pellucida, the thick layer surrounding the egg. Females infected with one of the transgenic viruses produce antibodies against their own eggs, damaging them and blocking fertilisation- a process called immunocontraception.

For rabbits, geneticists chose to engineer the myxoma virus, which devastated populations when it was released in Australia half century ago. But many rabbits have become resistant, and less lethal strains have edged out the original virus.

Four years ago, researchers selected the rabbit ZPB gene as the most promising of three zona pellucida genes to insert into the myxoma virus. But this sterilised less than 25 per cent of rabbits. Now they have switched to the ZPC gene, with much better results.

In two trials in May, New Scientist has learned, the latest transgenic myxoma virus sterilised 8 out of 11 female domestic r
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
7-Aug-2002


Page: 1 2 3

Related biology news :

1. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
2. UT Southwestern researchers discovery may lead to gene targets for new form of contraceptive
3. Oral contraceptives increase C-reactive protein, an infIammatory biomarker
4. Sperm and germ-fighting contraceptive enters trials
5. Newly found estrogen role in males might lead to contraceptive for men
6. New study shows oral contraceptive may be effective in treating severe form of premenstrual syndrome
7. Berlex Laboratories announces FDA approval of YASMIN (R), new oral contraceptive with unique progestin
8. Study suggests newer oral contraceptives may be less harmful for women smokers
9. Missing genes may help explain why plague bacteria are so deadly
10. Scripps scientists say genetic mutation doesnt protect against HIV and plague
11. AVANT to develop an oral anthrax and plague vaccine for U.S. Department of Defense

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The contraceptive plague

(Date:10/22/2014)... -- Leading identity analyst firm Acuity Market Intelligence forecasts that ... will have a chip-based National eID card, including near-complete ... Asia , with its vast population, is ... 60% of all National eID cards issued between 2014 ... National eID Industry Report: 2014 Edition" — ...
(Date:10/18/2014)... Berlin, 19th October 2014 Psychological stress and stress-related ... for aging-related diseases, but the molecular mechanisms ... mechanisms may contribute to the development of ... treatments for these devastating diseases. This work ... Neuropsychopharmacology congress in Berlin., Now an international ...
(Date:10/17/2014)... – Accurate knowledge regarding Ebola is critical and pertinent ... of hazardous global outbreak and epidemic. The Journal, ... a special issue, Ebola Virus and Public Health, to ... knowledge in this critical societal moment. , On ... Ebola for Clinicians . The primer was prepared by ...
Breaking Biology News(10 mins):Half the World's Population Will Have Chip-Based National Electronic Identity (eID) Cards by 2018 2Researchers find why depression and aging linked to increased disease risk 2
(Date:10/25/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... the development of oral drug delivery systems, announced today ... present at FireRock Capital,s Micro-Cap Conference. ... Tuesday, October 28, 2014 ,Time: 9:15am EST ,Location: The ... , About The FireRock Conference  ...
(Date:10/25/2014)... , Oct 24, 2014 Research ... "Epigenetics Market by Product , Research Area & ... report to their offering. In this ... basis of products, research areas, and end users. The ... report are enzymes, instruments & consumables, kits, and reagents. ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis plc ... pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced ... acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., which ... the treatment of diabetic gastroparesis and other GI functional ... Phase 2 trial of relamorelin for the treatment of ...
(Date:10/22/2014)... Massachusetts (PRWEB) October 22, 2014 ... announced the release of a new infographic, Understanding ... to create a beautifully designed, easy to follow informative ... transmission, areas of outbreak, symptoms and prevention. , "As ... discovered that the 2014 Ebola outbreak represents not only ...
Breaking Biology Technology:Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 2Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2
Cached News: